The India Ventures team have invested in PlasmaGen BioSciences, a Bengalaru based biopharma company that manufactures blood plasma derived products including Albumin and Immunoglobins.
PlasmaGen has a pan-India presence with a network of 200+ hospitals and 5,000+ clinics. It also sells its products outside of India.
Eight Roads sister fund, F-Prime, also participated in the round which is the first time PlasmaGenhas raised external funding. Prem Pavoor who led the investment said: "We have closely followed the blood plasma products segment over the past five years – we believe that India is rapidly catching up on global benchmarks around the awareness and use of these critical products." Prem and Robert Weiskoff from F-Prime will both join the PlasmaGen board.